RE: Sad times1 Apr 2022 01:05
Andy, yes, it has been planned prior, so I don't know why Kurt hasn't mentioned sooner than before year end. That's what I'm pondering. We have had the Danish economical study of Kal prospects, but I'm very surprised we have no immediate plan in place for unlocking value. We aren't privy to what happens behind closed doors, all we see at the moment is a shrinking share price after news that should only have driven the sp in an upwards direction. We now have a return to that low we saw before the concession. Why? Kurt has only touched upon this problem as a side comment in the last RNS, but I feel it needs investigating more closely by the Company. Losing over 65% of our value in little over a trading week on a positive concession result we've waited almost nine years for is scandalous, and Kurt has not even put out a separate qualifying RNS to even tell the market he knows of no reason for the mass selling, because everything is ok, no problems, kind of thing. I hope he regains his focus on better managing shareholder concerns and expectations via news, starting now! Meanwhile Andy, I'm back to pondering about the bloody scoping study. Simply put, recent news doesn't contain fine details. Details are what will help anyone looking to buy or even sell. What is the reason why the scoping study is before year end and not say before June and because of this or that? Fine details, helpful information should be standard practice, so let's have more explanations as to why in these RNS releases. Starting from now! Ffs.